Read, Watch or Listen

A federal jury handed Masimo a win in its longstanding legal battle with Apple, finding the company infringed a Masimo patent covering blood-oxygen monitoring technology visible in Apple Watch Workout and Heart Rate features. Apple disputed the verdict, saying the single patent expired in 2022 and is specific to historic patient monitoring technology from decades ago. The company plans to appeal.

Prepared by Christopher Adams and reviewed by editorial team.